跳至主要内容
临床试验/ITMCTR1900002593
ITMCTR1900002593招募中1 期

Parallel randomized controlled trial for Shengyang Yiwei Granule in the treatment of early Parkinson's disease

Kaida Wang0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • (1) Those who meet the diagnostic criteria of PD Chinese and Western medicine;
  • (2) TCM syndrome differentiation belongs to spleen and lung deficiency;
  • (3) Those aged 55-80 years;
  • (4) Modified HY stage <= 2.5;
  • (5) Conscious, vital signs are stable;
  • (6) Those who voluntarily accept this experimental study and informed consent.

排除标准

  • (1) Parkinson's syndrome and Parkinson's superposition syndrome caused by various causes such as cerebrovascular disease and poisoning;
  • (2) Those with major diseases such as severe liver and kidney, blood, tumor, endocrine disease or pain
  • (3) Those who are involved in other drug clinical trials;
  • (4) Psychiatric patients;
  • (5) Those who have a history of ugly drinking or a history of drug abuse.

研究者

发起方
Kaida Wang

相似试验